LDS/Medical Tests/Biopsy, Ovary

Biopsy, Ovary

An ovarian biopsy involves the removal of a small sample of ovarian tissue for microscopic examination. It is typically performed during surgery when abnormal ovarian tissue is identified. This procedure aids in diagnosing benign or malignant ovarian conditions, including neoplasms, infections, and inflammatory processes.

The ovarian biopsy is pivotal in distinguishing malignant from benign ovarian masses, identifying histological subtypes of ovarian tumors, and confirming diagnoses such as endometriosis or oophoritis. It is also instrumental in fertility evaluations and in guiding treatment decisions for ovarian pathology.

  • As an aid in the diagnosis of ovarian malignancy
  • Help distinguishing malignant from benign ovarian mass
  • Identifying histological subtypes of ovarian cancer
  • As an aid in the diagnosis endometriosis or oophoritis

Abnormal Presence of malignant cells may indicate ovarian carcinoma; inflammatory changes may indicate oophoritis.

Normal Normal biopsy is when no pathological changes were found

No abnormal pathological findings

Histopathological examination of formalin-fixed, paraffin-embedded ovarian tissue using hematoxylin and eosin (H&E) staining, and if indicated, immunohistochemistry (IHC) for tumor markers such as CA-125, WT1, or inhibin.

Tissue should be collected aseptically during surgery, immediately placed in 10% neutral buffered formalin, and transported to the pathology lab. Avoid crush artifacts and ensure adequate fixation.

Immunohistochemistry (IHC), molecular testing for BRCA mutations, tumor marker assays, cytogenetic analysis.
Usually, 24 hours for routine light microscopy, longer for immunohistochemical stains, which varies from case to case.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Reprod Med. 1972 Oct;9(4):161-7. [PMID: 4263245]
  • J Vasc Interv Radiol. 2014 Dec;25(12):1922-1927. [PMID: 25241300]
  • WHO Classification of Tumors: Female Genital Tumors, 5th Edition; College of American Pathologists (CAP) Biopsy Guidelines; NCCN Clinical Practice Guidelines in Oncology.